Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03039647 · ClinicalTrials.gov registry record
Insulin Resistance and Accelerated Cognitive Aging
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 126
- Enrollment target
NCT03039647: Completed study, sponsored by Stanford University.
NCT03039647 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03039647 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
Premature and accelerated brain aging trajectories have been observed among people with metabolic dysfunction, but mechanisms of these altered trajectories are not understood. Insulin resistance (IR) is known to change with age and affect cognition in older and elderly adults as well as in patients with mood disorders. The main purpose of the study is to describe the developmental trajectory of cognitive and neural biomarkers across the spectrum of metabolic dysfunction in overweight/obese adults younger than 50 years of age. The innovative study design will allow the investigators to examine cognitive outcome development over a 25-year span without an investment into the longitudinal observation of changes in cognition and neural function.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2022-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03039647
The ClinicalTrials.gov registry entry for NCT03039647 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03039647 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03039647 about?
NCT03039647 is a clinical study titled "Insulin Resistance and Accelerated Cognitive Aging". Premature and accelerated brain aging trajectories have been observed among people with metabolic dysfunction, but mechanisms of these altered trajectories are not understood. Insulin resistance (IR) is known to change with age and affect cognition in older and elderly adults as well as in patients ...
What is the current status of trial NCT03039647?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2017-01-01. Estimated completion is 2022-05-01.
Who is sponsoring clinical trial NCT03039647?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.